Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Main Article Content

Melissa Piliang
Charles Lynde
Brett King
Paradi Mirmirani
Rodney Sinclair
Robert Wolk
Samuel Zwillich
Helen Tran
Fan Zhang
Liza Takiya


ritlecitinib, alopecia areata


1. Islam N, et al. Autoimmun Rev. 2015;14:81-89.

2. King B, et al. Lancet 2023;401:1518-1529.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 > >>